Novelli E L, Rodrigues N L, Ribas B O
Departamento de Bioquímica, Universidade Estadual Paulista, São Paulo, Brazil.
Can J Physiol Pharmacol. 1988 May;66(5):663-5. doi: 10.1139/y88-104.
The potential of nickel chloride to prevent streptozotocin-induced hyperglycemia was tested in rats in vivo. To induce diabetes, streptozotocin (100 mg/kg body weight) was injected as a single dose. Streptozotocin treatment resulted in a significant decrease in plasma insulin and ceruloplasmin, and pancreatic Cu, protein, and Cu-Zn superoxide dismutase activity. In rats treated with nickel chloride (10 mg/kg body weight) and streptozotocin, these values were comparable with those observed in control rats. The results indicate that nickel chloride injected before streptozotocin prevented streptozotocin-induced hyperglycemia, and suggest that the protective effect was related to Cu-Zn superoxide dismutase activity, mediated by copper.
在大鼠体内测试了氯化镍预防链脲佐菌素诱导的高血糖的潜力。为诱导糖尿病,以单剂量注射链脲佐菌素(100毫克/千克体重)。链脲佐菌素治疗导致血浆胰岛素和铜蓝蛋白以及胰腺铜、蛋白质和铜锌超氧化物歧化酶活性显著降低。在用氯化镍(10毫克/千克体重)和链脲佐菌素治疗的大鼠中,这些值与在对照大鼠中观察到的值相当。结果表明,在链脲佐菌素之前注射氯化镍可预防链脲佐菌素诱导的高血糖,并表明保护作用与由铜介导的铜锌超氧化物歧化酶活性有关。